$ROL

UBS Sticks to Their Hold Rating for Rollins (ROL)

UBS analyst Joshua Chan reiterated a Hold rating on Rollins (ROL) and set a $43.00 price target. Other coverage cited includes Hold ratings from Canaccord Genuity and a Buy from Barclays. Rollins reported Q2 revenue of $1.08B and net profit of $143.91M, up from $999.53M revenue and $141.49M net profit a year earlier.

Original reporting
Published Jul 25, 2026, 1:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 9:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS Sticks to Their Hold Rating for Rollins (ROL) — source image
Decision brief

The 30-second read

$ROLNeutralLow
01

Why it matters

For traders, the actionable element is the specific target level and the fact that multiple banks reiterated ratings on the same day. However, the text does not include a new earnings surprise, guidance update, or catalyst beyond analyst stance.

02

Market read

This is primarily an analyst-coverage update with a stated target and mixed peer ratings, plus a recap of recent quarterly results.

03

What to watch

The article does not provide the analyst’s thesis, valuation assumptions, or any new guidance change, so the trading edge is mostly sentiment rather than fundamentals.

Relevance 4/10Novelty 4/10Timing: today’s analyst note and price-target reiteration

Background

The article reports UBS analyst Joshua Chan maintained a Hold rating on Rollins and set a $43.00 price target, referencing other firms’ same-day ratings.

Company-level read

Ticker impact

$ROLNeutralMedium confidence
Context

UBS maintained a Hold on Rollins and set a $43.00 price target, alongside other banks’ same-day Hold/Buy stances.

Expected impact

Likely modest, sentiment-driven reaction at most, with limited follow-through unless other analysts change targets or fundamentals shift.

Evidence & confidence

The article’s concrete new facts are the UBS Hold and $43 target, plus same-day mentions of other firms’ ratings. It also repeats quarterly revenue and net profit figures without indicating a fresh earnings surprise or guidance change.

Market effects

Read-across is limited because the piece is primarily about one company’s analyst coverage rather than a sector catalyst.

No clear regional macro or cross-market catalyst is disclosed.

No global event or supply-chain/regulatory driver is mentioned.

Counterpoint

If the $43 target is broadly aligned with Street expectations, the reiteration may not move the stock meaningfully; traders may discount it as routine coverage.

Key entities

  • Rollins

    US pest-control company covered by UBS; subject of the Hold rating and $43 price target in the article.

  • UBS

    Issued the Hold rating and $43.00 price target cited in the article.

  • Barclays

    Maintained a Buy rating on Rollins in a report issued today, per the article.

  • Canaccord Genuity

    Issued a Hold rating on Rollins in a report issued today, per the article.

Related articles

$ROLMedAI 8/10

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

$ROLMed

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

$ROLMedAI 8/10

Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings - Rollins (NYSE:ROL)

Rollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.

$ROLMed

Wells Fargo says ditch this pest control stock as demand continues to soften

Wells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.